Top

Intensive Care Medicine

Published in:

01-03-2008 | Pediatric Original

Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

Authors: Dincer Yildizdas, Hacer Yapicioglu, Umit Celik, Yasar Sertdemir, Emre Alhan

Published in: Intensive Care Medicine | Issue 3/2008

Abstract

Objective

To evaluate the effect of terlipressin on oxygenation, PaO₂/FIO₂, heart rate, mean arterial pressure, and mortality in children with septic shock refractory to high doses of dopamine/dobutamine and adrenaline.

Design and setting

A randomized, nonblind study in the pediatric intensive care unit of a university hospital.

Patients and measurements

We studied 58 children with septic shock and refractory hypotension despite fluid loading and high doses of catecholamines, randomly enrolled to terlipressin (TP, n = 30) or control (n = 28). TP was administered as intravenous bolus doses of 20 μg/kg every 6 h for a maximum of 96 h. Hemodynamic changes, PaO₂/FIO₂ rates, length of stay, and mortality rate in PICU were recorded prospectively.

Results

Mean arterial pressure and PaO₂/FIO₂ significantly increased, and heart rate significantly decreased 30 min after each TP treatment, but mortality did not differ from control (67.3% vs. 71.4%). Mean stay in the PICU was shorter in the TP group (13.4 ± 7.9 vs. 20.2 ± 9.7 days and was longer among nonsurvivors of the TP group vs. control (10.4 ± 6.9 vs. 6.2 ± 3.4 days). Blood urea nitrogen, creatinine, AST, ALT, and urine output of patients in the TP group did not change after terlipressin.

Conclusions

Although terlipressin infusion had no effect on mortality, it significantly increases mean arterial pressure, PaO₂/FIO₂, and survival time in nonsurvivors. Terlipressin seems to cause no adverse effect but warrants further evaluation as a rescue therapy in refractory septic shock.

Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167:695–701PubMedCrossRef

Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 45:588–595CrossRef

Meyer J, Booke M, Waurick R, Prien T, van Aken H (1996) Nitric oxide synthase inhibition restores vasopressor effects of norepinephrine in ovine hyperdynamic sepsis. Anesth Analg 83:1009–1013PubMedCrossRef

Holmes CL, Patel BM, Russell JA (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–999PubMedCrossRef

Landry DW, Oliver JA (1992) The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071–2074PubMedCrossRef

Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent J-L, Levy MM (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–870PubMedCrossRef

Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31:946–955PubMedCrossRef

Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent J-L, Zanotti-Cavazzoni S (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928–1948PubMedCrossRef

Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103:1826–1831PubMedCrossRef

10.

Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD (1987) A reappraisal of norepinehrine therapy in human septic shock. Crit Care Med 15:134–137PubMedCrossRef

11.

Reinhart K, Saka SG, Meier-Hellman A (2000) Haemodynamic management of a patient with septic shock. Eur J Anaeasthesiol 17:6–17CrossRef

12.

Schreuder WO, Schneider AJ, Groeneveld AB, Thijs LG (1989) Effect of dopamine versus norepinephrine on hemodynamic in septic shock: emphasis on right ventricular performance. Chest 95:1282–1288PubMedCrossRef

13.

Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279–1282PubMedCrossRef

14.

Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, Erlinger S, Lebrec D (1998) Beneficial effects of 2 day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 29:565–570PubMedCrossRef

15.

Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582PubMedCrossRef

16.

O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine resistant septic shock. Lancet 359:1209–1210PubMedCrossRef

17.

Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez-Alanso N, Martinon-Sanchez JM (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30:477–480PubMedCrossRef

18.

Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z, Paret G (2004) Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 5:116–118PubMedCrossRef

19.

Peters M, Booth RA, Petros AJ (2004) Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr Crit Care Med 5:112–115PubMedCrossRef

20.

Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597–604PubMedCrossRef

21.

Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C (2004) Terlipressin in catecholamine-resistant septic shock patients. Shock 22:314–319PubMedCrossRef

22.

Matok I, Vard A, Efrati O, Rubinshtein M, Vishne T, Leibovitch L, Adam M, Barzilay Z, Paret G (2005) Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 23:305–310PubMedCrossRef

23.

Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, Hernandez A, Rey C, RETSPED Working Group of the Spain Society of Pediatric Intensive Care (2006) Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 10:1–8

24.

Siegfried BH, Henderson TO (2002) Cardiology. In: Gunn VL, Nechyba C (eds) The Harriet Lane Handbook, 16th edn. Elsevier Science, Philadelphia, pp 123–168

25.

Greenfield MM (2002) Pulmonology. In: Gunn VL, Nechyba C (eds) The Harriet Lane Handbook, 16th edn. Elsevier Science, Philadelphia, pp 513–527

26.

Hayden WR (1994) Sepsis terminology in pediatrics. J Pediatr 124:657–658PubMed

27.

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 19:973–976

28.

Abboud FM, Floras JS, Aylward PE, Guo GB, Gupta BN, Schmid PG (1990) Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 27:106–115PubMed

29.

Sharshar T, Blanchard A, Paillard M, Paphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752–1758PubMedCrossRef

30.

Delmas A, Leone M, Rousseau S, Albanese J, Martin C (2005) Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care 9:212–222PubMedCrossRef

31.

Malay MB, Ashton RC Jr, Landry DW, Townsend RN (1999) Low dose of vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699–703PubMed

32.

Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR (2003) Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 107:2313–2319PubMedCrossRef

33.

Albanase J, Leone M, Delmas A, Martin C (2005) Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33:1897–1902CrossRef

34.

Undesser KP, Hasser EM, Haywood JR, Johnson AK, Bishop VS (1985) Interactions of vasopressin with the postrema in arterial baroreflex function in conscious rabbits. Circ Res 56:410–417PubMed

35.

Evora PR, Pearswon PJ, Schaff HV (1993) Arginine vasopressin induces endothelium-dependent vasodilation of pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 103:1241–1245PubMedCrossRef

36.

Mutlu GM, Factor P (2004) Role of vasopressin in the management of septic shock. Intensive Care Med 30:1276–1291PubMed

37.

Edwards RM, Trizna W, Kinter LB (1989) Renal effects of vasopressin and vasopressin antagonists. Am J Physiol 256:F274–278PubMed

38.

Ceneviva G, Paschall AJ, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19PubMedCrossRef

39.

Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M (1996) Epidemiology of sepsis and multiorgan dysfunction syndrome in children. Chest 109:1033–1037PubMedCrossRef

40.

Goh A, Chan PWK, Lum LCS (1999) Sepsis, severe sepsis and septic shock in paediatric multiorgan dysfunction syndrome. J Paediatr Child Health 35:488–492PubMedCrossRef

Title: Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children
Authors: Dincer Yildizdas
Hacer Yapicioglu
Umit Celik
Yasar Sertdemir
Emre Alhan
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 3/2008
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-007-0971-x

At a glance: The STEP trials

Springer Medicine

Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

Abstract

Objective

Design and setting

Patients and measurements

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Design and setting

Patients and measurements

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2008

Reply to the comment by Dr. Borges

Year in review in Intensive Care Medicine, 2007. II. Haemodynamics, pneumonia, infections and sepsis, invasive and non-invasive mechanical ventilation, acute respiratory distress syndrome

Announcement

Preserved spontaneous breathing in acute lung injury: show me the money?

Electrical impedance tomography: a future item on the “Christmas Wish List” of the intensivist?

Reply to the Editor-in-Chief